Regal Assets Analytics

WDLangbein

About Bill Langbein

Before starting SanaCurrents, William (Bill) Langbein spent more than 20 years as a life science business journalist, with stops at California Medicine, In Vivo and Reuters Health. During that time, he wrote on genomic discoveries, the transition of the pharmaceutical companies to rely more on biologics, and the dawn of precision medicine, through which most drug developers came to recognize a one-drug-for-all approach would no longer work. One constant truth he learned is smaller companies deliver the most innovation and highest value to patients and investors. Yet because of the inherent volatility of biopharma and medical devices, small companies typically fly under the radar of investors. The emergence of precision medicine, however, reduces the volatility of small cap companies and increases the potential for strong returns. SanaCurrents was founded to identify the undervalued therapies that would benefit patients and investors the most.

Kiniska Pharmaceuticals (KNSA) Probability Sentiment

By |2020-03-28T13:37:50-04:00March 28th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Probability Sentiment [...]

Arcturus Therapeutics (ARCT) Probability Sentiment

By |2020-03-30T10:10:58-04:00March 21st, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

Arcturus Therapeutics Holdings (NASDAQ:ARCT) Probability Sentiment [...]

Erytech Pharma (EYRP) Probability Sentiment

By |2020-03-21T11:12:47-04:00March 14th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Erytech Pharma S.a. (NASDAQ:ERYP) Probability Sentiment [...]

Cassava Sciences (SAVA) Probability Sentiment

By |2020-03-30T10:11:21-04:00March 7th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Cassava Sciences, Inc. (NASDAQ:SAVA) Probability Sentiment [...]

Selecta Biosciences (SELB) Probability Sentiment

By |2020-03-30T10:11:48-04:00February 22nd, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Selecta Biosciences, Inc. (NASDAQ:SELB) Probability Sentiment [...]

Agile’s Twirla FDA Approval Helps Shares

By |2020-03-30T10:11:59-04:00February 19th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|

Agile Therapeutics, Inc. (NASDAQ:AGRX) announced FDA approval of its contraceptive [...]